Scilex Holding (SCLXW) Net Cash Flow (QoQ) (2020 - 2026)

Scilex Holding (SCLXW) Net Cash Flow (QoQ) (2020 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Scilex Holding - - 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -77.57%
Dec 31, 2025 248.07%
Sep 30, 2025 -96.86%
Jun 30, 2025 -165.59%
Mar 31, 2025 152.19%
Dec 31, 2024 -212.52%
Sep 30, 2024 -122.49%
Jun 30, 2024 452.53%
Mar 31, 2024 -171.12%
Dec 31, 2023 108.29%
Sep 30, 2023 -210.28%
Jun 30, 2023 941.84%
Mar 31, 2023 1,064.88%
Dec 31, 2022 93.11%
Sep 30, 2022 83.11%
Jun 30, 2022 -191.18%
Mar 31, 2022 4,910.19%
Dec 31, 2021 99.58%
Sep 30, 2021 -61,876.55%
Jun 30, 2021 -20.15%